statistically significant improvement

Related by string. Statistically Significant Improvement * Statistically . STATISTICALLY : demonstrated statistically significant . statistically significant differences . statistically significant correlation / signifi cant . sig nificant : statistically significant reduction . Significant Items / improvements . Improvements : Needs Improvement . Improvement Plan * *

Related by context. Frequent words. (Click for all words.) 69 statistically significant reduction 65 statistically significant 64 primary endpoint 64 secondary endpoints 63 primary efficacy endpoint 63 statistically significant differences 63 demonstrated statistically significant 63 placebo 62 secondary endpoint 60 p = #.# [002] 60 placebo p = 59 evaluable 59 placebo p 58 clinically meaningful 58 p = #.# [004] 58 mg dose 58 evaluable patients 57 primary endpoints 57 etanercept 57 p = 56 P = .# 56 tumor shrinkage 56 free survival PFS 55 tiotropium 55 docetaxel 55 n = 55 mg BID 55 mg kg 54 plus ribavirin 54 FEV1 54 reach statistical significance 54 non inferiority 54 randomized 53 HbA1c levels 53 clinically relevant 53 monotherapy 53 statistical significance 53 dose limiting toxicities 53 pharmacodynamic 52 FOLFOX 52 52 depressive symptoms 52 exacerbations 52 tumor regression 52 pramipexole 51 LEVADEX 51 Efficacy 51 dexamethasone 51 HbA1c 51 postoperatively 51 quetiapine 51 HCV RNA 51 mg d 51 tolerability 51 bevacizumab 51 treatment emergent adverse 51 fluoxetine 50 pioglitazone 50 infliximab 50 sunitinib 50 placebo controlled 50 randomized controlled 50 tolerability profile 50 pemetrexed 50 febrile neutropenia 50 copies mL 49 antitumor activity 49 dyspnea 49 ACTEMRA 49 Phase 2b study 49 randomized placebo controlled 49 disease progression 49 olanzapine 49 aripiprazole 49 Adverse events 49 azathioprine 49 histologic 49 plasma concentrations 49 citalopram 48 μg 48 donepezil 48 erythema 48 unblinded 48 certolizumab pegol 48 escitalopram 48 randomized clinical 48 proteinuria 48 double blind placebo 48 risperidone 48 preoperative 48 antiviral activity 48 pegylated interferon 48 gemcitabine 48 pharmacokinetic 48 Median survival 48 lubiprostone 48 visual acuity 47 imatinib 47 erlotinib 47 mg doses 47 cetuximab

Back to home page